Literature DB >> 29526130

Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma.

Emilia Cocorocchio1, Laura Pala1, Angelo Battaglia1, Sara Gandini2, Fedro Alessandro Peccatori3, Pier Francesco Ferrucci1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29526130     DOI： 10.1080/0284186X.2018.1449251

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

Review 1.  [Andrological consultation in new systemic oncological therapies with small molecules].

Authors:  Till Weidner; Uwe Paasch; Sonja Grunewald
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

2.  Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report.

Authors:  Marco Ghezzi; Andrea Garolla; Sabina Magagna; Iva Šabovich; Massimiliano Berretta; Carlo Foresta; Luca De Toni
Journal:  Front Oncol       Date:  2020-03-05       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.